Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001415889-23-004313

CEO acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
O'Neill Gilmore Neil CEO 2023-03-02 Grant or award +50,000 136,655 D
Derivatives
O'Neill Gilmore Neil CEO 2023-03-02 Grant or award · Stock Option (right to buy) +150,000 150,000 D
Loading xslF345X03/form4-03062023_040304.xml…